Microbiology and Antimicrobial Discovery
Our scientists study the biology, genetics, and ecological roles of microbes. They identify and develop new antibiotics to combat drug-resistant pathogens. This research addresses critical public health challenges by creating therapeutic strategies against infectious diseases and emerging microbial threats.
Members
-
Dr. Chai is interested in understanding fundamental mechanisms controlling bacterial biofilm formation and the role of beneficial biofilms in bacteria-host interactions.
-
Research in Dr. Epstein’s lab is focused on microbial discovery in the environment and human microbiome.
-
The Geisinger Lab investigates the molecular basis of antibiotic resistance and disease development in infections with hospital-acquired pathogens.
-
The Godoy Lab investigates the regulation of the bacterial DNA damage responses (DDR) and the mutagenic Y-family DNA polymerases that are part of the DDR.
-
Researchers in the Lewis Lab study several related subjects – persister cells, microbiomes, and uncultured bacteria – enabling their work on antibiotic discovery.
-
The Saavedra Lab investigates host-microbe interactions in health and disease through an immunology and cell biology lens.
-
Dr. Santos aims to uncover how bacteria manufacture and install stabilizing protein entities into cell walls, which could form the basis of new antibiotics.
-
The Takacs Lab studies the Lyme disease bacterium, Borrelia burgdorferi, its tick vector, and their interactions through a set of genetic, imaging, and biochemical approaches.